Annual Federal Funding Recommendations
Biomedical and Related Life Sciences Research, FY 2022
Federal investments in investigator-initiated research have enabled remarkable progress in the biological and biomedical sciences. Robust, predictable, and sustained budget increases for science agencies, across a range of fields, are the only way to ensure continuing advances in healthcare, new treatments for life-threatening diseases, and enhanced quality of life.
These are FASEB’s fiscal year (FY) 2022 funding recommendations for these federal agencies: